Arcutis
IPO News: Filed S-1: Arcutis Biotherapeutics, Inc Files $100mm IPO
Arcutis

Arcutis Biotherapeutics, Inc

NASDAQ:  ARQT

Size (mm):  $100.0

Bookrunners:  GS | COWN | GUGG | CANTOR

Major Holders:  Bain Capital | Frazier Life Sciences | OrbiMed

Description:  Arcutis Biotherapeutics is a late-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs.

Note:  Emerging Growth Company

 

Reference Link:  S-1